News | November 15, 2022
IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company sees the business reaching $100mn
Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers
The company has successfully developed Methyl salicylate using Flow Chemistry and successfully erected a Flow reactor at Jhagadia plant and expects to start production from Q3 FY23
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
Subscribe To Our Newsletter & Stay Updated
